Australia's largest stock trading and investment forum Australia's #1 stock forum

FAR first australian resources limited

0.00%

30.0¢

Talk about something else please, page-2

First 2 Last

Share
Profile

Follow
Mr.Hustler

3,240 Posts.

38

26/03/18

06:49

Post #: 32014447
Share

Originally posted by gus63 ↑

The Arbitration will take at least 9 months more and CoP will try and delay that as much as possible, so I doubt we will hear anything until 2019. So Please can we stop going around and around on something that we do not have all the details on and never well and an independent commission will make a finding in due course. There must be more important things to discuss, if not then you should not feel compelled to post something!

Did anyone notice that Brent was back over$70 last week or were you all to occupied with Declaratory Relief!

JIMHO.

Expand

Hi Gus,

Yes I noticed the price of Brent as I do read up but thought the price fluctuations we are seeing now as largely unimportant as we won't be producing for a couple of years.

Brent will matter earlier if we get a TO offer or get that "declaratory relief" you don't want to hear about and have something to sell.

JIMHO

FAR Price at posting: 7.8¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

TGN

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

NVA

Nova Minerals achieves key milestone on path to Alaskan antimony production

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

D3E

D3 Energy detects gas in South African helium hunt well

IMR

Imricor Med and Philips launch commercial iMR lab solution

AS2

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

MEM

Memphasys receives early Thai FDA Felix approval

SEN

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

4DX

4DMedical posts FY26 revenue growth as commercial deployment ramps up

CVL

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

There are more pages in this discussion • 12 more messages in this thread...

First 2 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 30.0¢		Change 0.000(0.00%)		Mkt cap ! $27.72M

Open	High	Low	Volume
0.0¢	0.0¢	0.0¢	0

Buyers (Bids)

Vol.	Price($)
80988	28.0¢

Sellers (Offers)

Price($)	Vol.
30.5¢	7234

Last trade - 10.09am 28/08/2026 (20 minute delay)

FAR (ASX) Chart

Day chart unavailable

Talk about something else please, page-2

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Nova Minerals achieves key milestone on path to Alaskan antimony production

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

D3 Energy detects gas in South African helium hunt well

Imricor Med and Philips launch commercial iMR lab solution

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Memphasys receives early Thai FDA Felix approval

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

4DMedical posts FY26 revenue growth as commercial deployment ramps up

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Talk about something else please, page-2

Top Stories

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Nova Minerals achieves key milestone on path to Alaskan antimony production

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

D3 Energy detects gas in South African helium hunt well

Imricor Med and Philips launch commercial iMR lab solution

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Memphasys receives early Thai FDA Felix approval

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

4DMedical posts FY26 revenue growth as commercial deployment ramps up

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News